Valtensam Comp 10 mg/ 160 mg/ 25 mg Filmdragerad tablett

国: スウェーデン

言語: スウェーデン語

ソース: Läkemedelsverket (Medical Products Agency)

即購入

製品の特徴 製品の特徴 (SPC)
16-04-2020

有効成分:

amlodipinbesilat; hydroklortiazid; valsartan

から入手可能:

Teva B.V.

ATCコード:

C09DX01

INN(国際名):

amlodipinbesilat; hydrochlorothiazide; valsartan

投薬量:

10 mg/ 160 mg/ 25 mg

医薬品形態:

Filmdragerad tablett

構図:

laktosmonohydrat Hjälpämne; valsartan 160 mg Aktiv substans; amlodipinbesilat 13,86 mg Aktiv substans; hydroklortiazid 25 mg Aktiv substans

処方タイプ:

Receptbelagt

製品概要:

Förpacknings: Blister, 14 tabletter; Blister, 28 tabletter; Blister, 30 tabletter; Blister, 56 tabletter; Blister, 90 tabletter; Blister, 98 tabletter; Burk, 100 tabletter

認証ステータス:

Avregistrerad

承認日:

2020-04-15

製品の特徴

                                1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Valtensam Comp 10 mg/160 mg/12.5 mg film-coated tablets
Valtensam Comp 5 mg/160 mg/25 mg film-coated tablets
Valtensam Comp 10 mg/160 mg/25 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each film-coated tablet contains amlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 12.5 mg of hydrochlorothiazide.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 5 mg
amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
Excipient(s) with known effect
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet)
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Oval, light yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIL on
one side of the tablet.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Oval, yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIH on one
side of the tablet
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Oval, dark yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIT on
one side of the tablet.
2
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of essential hypertension as substitution therapy in adult
patients whose blood pressure is
adequately controlled on the combination of amlodipine, valsartan and
hydrochlorothiazide (HCT),

                                
                                完全なドキュメントを読む
                                
                            

他の言語のドキュメント

情報リーフレット 情報リーフレット 英語 12-08-2022
製品の特徴 製品の特徴 英語 12-08-2022
公開評価報告書 公開評価報告書 英語 27-05-2020